COMPARISON
Ganirelix vs Triptorelin
5 attributes held for at least one of the two. 4 differ. Each value carries the register it came from and the date that register was read.
Answer
Ganirelix is authorised or registered in 10 and Triptorelin in 10 of the 10 registers read. Ganirelix: highest phase Phase 4 (after approval). Triptorelin: highest phase Phase 4 (after approval). 17 registered trials include both.
States no view on which is preferable, safer or more effective. Not medical advice.
| Ganirelix | Triptorelin | |
|---|---|---|
| Registered trials differs | 108 clinicaltrials.gov · 2026-10-03 | 317 clinicaltrials.gov · 2026-10-03 |
| FDA label differs | FDA-approved: Ganirelix Acetate openfda · 2026-10-03T17:23:44.062Z | FDA-approved: Trelstar openfda · 2026-10-03T17:23:44.062Z |
| EU authorisation | Authorised ema · 2026-10-03 | Authorised ema · 2026-08-31 |
| EU authorised on differs | 2000-05-16 ema · 2026-10-03 | Not checked no record of "authorisedOn" for triptorelin |
| ATC code differs | H01CC01 ema · 2026-10-03 | Not checked no record of "atcCode" for triptorelin |
LEGAL STATUS
Approval in each country read
| Country | Ganirelix | Triptorelin | Register |
|---|---|---|---|
| United States | FDA-approved | FDA-approved | Regulator FDA |
| European Union | Authorised | Authorised | Regulator EMA |
| United Kingdom | Authorised | Authorised | Regulator MHRA |
| Canada | Authorised | Authorised | Regulator Health Canada |
| Australia | Registered | Registered | Regulator TGA |
| Switzerland | Authorised | Authorised | Regulator Swissmedic |
| Brazil | Registado | Registado | Regulator ANVISA |
| Serbia | Authorised | Authorised | Regulator ALIMS |
| Singapore | Registered | Registered | Regulator HSA |
| Turkey | Ruhsatli | Ruhsatli | Regulator TITCK |
HEAD TO HEAD
17 registered trials include both
| NCT06481696 | Possible Action of Resveratrol in Improving the Outcomes of IVF/ICSI in Couples With Unexplained Infertility UNKNOWN · updated 2024-07-01 |
|---|---|
| NCT04586686 | Combining Interventions of Fertility Preservation to Mitigate Fertility Loss After Breast Cancer UNKNOWN · updated 2023-05-18 |
| NCT04616729 | DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation UNKNOWN · updated 2023-05-18 |
| NCT04071574 | Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility COMPLETED · updated 2023-05-09 |
| NCT00725491 | A Study to Assess the Efficacy and Safety of Ganirelix (Orgalutran®) Treatment in Chinese Women Undergoing Controlled Ovarian Stimulation for in Vitro Fertiliza COMPLETED · updated 2022-02-03 |
| NCT04854707 | An Observational Study of Follitropin Alpha Biosimilar: the Real-world Data COMPLETED · updated 2021-10-22 |
| NCT03291821 | DuoStim in Cases of PGT: Comparison of Embryo Quantity and Embryonic Quality Using MitoScore COMPLETED · updated 2020-12-29 |
| NCT01590173 | Addition of Prednisolone and Heparin in Patients Undergoing IVF With Failed IVF Cycles COMPLETED · updated 2016-07-19 |
| NCT01798862 | Endometrial Injury and IVF Outcome Parameters in Patients With Failed IVF Cycles COMPLETED · updated 2016-06-10 |
| NCT01206803 | Ovarian Response Prediction in In Vitro Fertilization (IVF) Patients COMPLETED · updated 2016-01-05 |
| NCT02635607 | Effectiveness and Safety Study of Fixed Versus Flexible of Gonadotropin-releasing Hormone Antagonist Protocol UNKNOWN · updated 2015-12-21 |
| NCT00417066 | Flexible GnRH Antagonist vs Flare up GnRH Agonist Protocol in Poor Responders COMPLETED · updated 2013-12-16 |
| NCT00866008 | A Study of the Effects of a Novel Ovarian Stimulation Regimen on Embryo Aneuploidy Rates in In Vitro Fertilization (IVF) TERMINATED · updated 2013-07-22 |
| NCT00985062 | Mild Versus Conventional Ovarian Stimulation Treatment for In Vitro Fertilization COMPLETED · updated 2009-09-28 |
| NCT00635258 | Administration of GnRH Antagonist to Oocyte Donation Recipients COMPLETED · updated 2008-03-13 |
| NCT00417144 | Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients UNKNOWN · updated 2006-12-29 |
| NCT00417183 | Comparison of the Long GnRH Agonist Protocol and the Flexible GnRH Antagonist Protocol of Ovarian Stimulation UNKNOWN · updated 2006-12-29 |
Values reproduce public registers on the dates shown. This comparison states no view on which compound is preferable, safer or more effective. Not medical, legal or regulatory advice.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.